Akari Therapeutics PLC (AKTX)

2.44 +0.01 (+0.41%) USD  |  NASDAQ  |  Nov 08, 16:00
2.21 -0.23 (-9.43%) After-Hours: 20:00
More

Akari Therapeutics Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to . Upgrade now.
Date Value

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

DBV Technologies SA --
Cellectis SA Upgrade
Adaptimmune Therapeutics PLC Upgrade
Biodexa Pharmaceuticals PLC --
NuCana PLC --